Hiroyuki Ochi

1.3k total citations
43 papers, 974 citations indexed

About

Hiroyuki Ochi is a scholar working on Surgery, Reproductive Medicine and Epidemiology. According to data from OpenAlex, Hiroyuki Ochi has authored 43 papers receiving a total of 974 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 13 papers in Reproductive Medicine and 12 papers in Epidemiology. Recurrent topics in Hiroyuki Ochi's work include Ovarian cancer diagnosis and treatment (11 papers), Cervical Cancer and HPV Research (9 papers) and Endometrial and Cervical Cancer Treatments (7 papers). Hiroyuki Ochi is often cited by papers focused on Ovarian cancer diagnosis and treatment (11 papers), Cervical Cancer and HPV Research (9 papers) and Endometrial and Cervical Cancer Treatments (7 papers). Hiroyuki Ochi collaborates with scholars based in Japan, India and Somalia. Hiroyuki Ochi's co-authors include Toyomi Satoh, Hiroyuki Yoshikawa, Koji Matsumoto, Takeo Minaguchi, M Sakurai, Mamiko Onuki, Akinori Oki, Kazunari Kondo, Tadahito Kanda and Hiroyuki Yoshikawa and has published in prestigious journals such as PLoS ONE, British Journal of Cancer and IEEE Transactions on Medical Imaging.

In The Last Decade

Hiroyuki Ochi

40 papers receiving 952 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroyuki Ochi Japan 18 375 227 214 209 173 43 974
Mamiko Onuki Japan 16 292 0.8× 142 0.6× 155 0.7× 176 0.8× 111 0.6× 36 708
Cornelis A. Seldenrijk Netherlands 17 229 0.6× 72 0.3× 33 0.2× 438 2.1× 18 0.1× 42 1.2k
Gun Oh Chong South Korea 20 219 0.6× 353 1.6× 583 2.7× 333 1.6× 5 0.0× 116 1.2k
Sharon Mount United States 20 527 1.4× 327 1.4× 357 1.7× 340 1.6× 4 0.0× 65 1.3k
Karin Denton United Kingdom 17 709 1.9× 42 0.2× 80 0.4× 462 2.2× 7 0.0× 35 1.1k
Chhanda Bewtra United States 21 214 0.6× 493 2.2× 199 0.9× 178 0.9× 3 0.0× 53 1.4k
George Hamilos Greece 12 83 0.2× 91 0.4× 45 0.2× 99 0.5× 10 0.1× 20 829
Moni Roy United States 13 204 0.5× 424 1.9× 318 1.5× 246 1.2× 3 0.0× 52 995
Koji Kanazawa Japan 24 508 1.4× 358 1.6× 618 2.9× 399 1.9× 2 0.0× 65 1.4k
P. J. Simpson‐Haidaris United States 12 155 0.4× 16 0.1× 12 0.1× 104 0.5× 48 0.3× 17 776

Countries citing papers authored by Hiroyuki Ochi

Since Specialization
Citations

This map shows the geographic impact of Hiroyuki Ochi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroyuki Ochi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroyuki Ochi more than expected).

Fields of papers citing papers by Hiroyuki Ochi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroyuki Ochi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroyuki Ochi. The network helps show where Hiroyuki Ochi may publish in the future.

Co-authorship network of co-authors of Hiroyuki Ochi

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroyuki Ochi. A scholar is included among the top collaborators of Hiroyuki Ochi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroyuki Ochi. Hiroyuki Ochi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Chenyang, Takeo Minaguchi, Nan Qi, et al.. (2022). Differential roles of the Wip1–p38–p53 DNA damage response pathway in early/advanced-stage ovarian clear cell carcinomas. World Journal of Surgical Oncology. 20(1). 139–139. 1 indexed citations
2.
3.
Nakao, Sari, Takeo Minaguchi, Ayumi Shikama, et al.. (2020). Pretreatment thrombocytosis as an independent predictive factor for chemoresistance and poor survival in epithelial ovarian cancer. Journal of Ovarian Research. 13(1). 55–55. 7 indexed citations
4.
Zhang, Shuang, Takeo Minaguchi, Chenyang Xu, et al.. (2020). PD-L1 and CD4 are independent prognostic factors for overall survival in endometrial carcinomas. BMC Cancer. 20(1). 127–127. 34 indexed citations
5.
Shikama, Ayumi, Takeo Minaguchi, Keiko Nishida, et al.. (2019). Predictors of favorable survival after secondary cytoreductive surgery for recurrent endometrial cancer. International Journal of Clinical Oncology. 24(10). 1256–1263. 17 indexed citations
6.
Minaguchi, Takeo, Azusa Akiyama, Shilin Liu, et al.. (2018). Prognostic significance of PIK3CA mutation in stage IIB to IVA cervical cancers treated by concurrent chemoradiotherapy with weekly cisplatin. Medicine. 97(31). e11392–e11392. 18 indexed citations
7.
Liu, Shuling, Takeo Minaguchi, Shuang Zhang, et al.. (2018). Separate analysis of human papillomavirus E6 and E7 messenger RNAs to predict cervical neoplasia progression. PLoS ONE. 13(2). e0193061–e0193061. 14 indexed citations
8.
Nakao, Sari, Yuki Kojima, Hiroko Itô, et al.. (2017). Paraneoplastic thrombocytosis as a prognostic marker in ovarian cancer. 69(2). 626.
9.
Sakurai, M, Koji Matsumoto, Masahiko Gosho, et al.. (2016). Expression of Tissue Factor in Epithelial Ovarian Carcinoma Is Involved in the Development of Venous Thromboembolism. International Journal of Gynecological Cancer. 27(1). 37–43. 28 indexed citations
10.
Nishida, Keiko, Nobutaka Tasaka, Ayumi Shikama, et al.. (2016). Possible de novo clear cell carcinoma in the contralateral ovary 9 years after fertility-sparing surgery for Stage IA clear cell ovarian carcinoma. International Cancer Conference Journal. 6(2). 50–54.
11.
Onuki, Mamiko, Koji Matsumoto, M Sakurai, et al.. (2015). Posttreatment human papillomavirus testing for residual or recurrent high-grade cervical intraepithelial neoplasia: a pooled analysis. Journal of Gynecologic Oncology. 27(1). e3–e3. 23 indexed citations
12.
Nakamura, Yuko, Koji Matsumoto, Toyomi Satoh, et al.. (2015). HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study. International Journal of Clinical Oncology. 20(5). 974–981. 16 indexed citations
13.
Sakurai, M, Toyomi Satoh, Koji Matsumoto, et al.. (2015). High Pretreatment Plasma D-dimer Levels Are Associated With Poor Prognosis in Patients With Ovarian Cancer Independently of Venous Thromboembolism and Tumor Extension. International Journal of Gynecological Cancer. 25(4). 593–598. 32 indexed citations
14.
Minaguchi, Takeo, Hiroyuki Ochi, Mamiko Onuki, et al.. (2012). Safety and efficacy of substituting nedaplatin after carboplatin hypersensitivity reactions in gynecologic malignancies. Journal of obstetrics and gynaecology research. 39(1). 330–335. 11 indexed citations
15.
Ochi, Hiroyuki, et al.. (2011). The persistence of drug-induced fever by teicoplanin – a case report. International Journal of Clinical Pharmacology and Therapeutics. 49(5). 339–343. 5 indexed citations
16.
Onuki, Mamiko, Koji Matsumoto, Toyomi Satoh, et al.. (2009). Human papillomavirus infections among Japanese women: age‐related prevalence and type‐specific risk for cervical cancer. Cancer Science. 100(7). 1312–1316. 111 indexed citations
17.
Satoh, Toyomi, Akinori Oki, K. Uno, et al.. (2007). High incidence of silent venous thromboembolism before treatment in ovarian cancer. British Journal of Cancer. 97(8). 1053–1057. 109 indexed citations
18.
19.
Ochi, Hiroyuki & Makoto Kiuchi. (1998). Application methods and toxic effects of an imidazole derivative, Triflumizole, in Bombyx mori. 67(4). 303–309. 1 indexed citations
20.
Tominaga, Koji, et al.. (1987). Cytogenetic effects of multiagent chemotherapy on the peripheral lymphocytes of patients with small cell lung cancer. Lung Cancer. 3(3-4). 145–146. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mamiko Onuki Breakdown of academic impact, for papers by Cornelis A. Seldenrijk Breakdown of academic impact, for papers by Gun Oh Chong Breakdown of academic impact, for papers by Sharon Mount Breakdown of academic impact, for papers by Karin Denton Breakdown of academic impact, for papers by Chhanda Bewtra Breakdown of academic impact, for papers by George Hamilos Breakdown of academic impact, for papers by Moni Roy Breakdown of academic impact, for papers by Koji Kanazawa Breakdown of academic impact, for papers by P. J. Simpson‐Haidaris
Rankless by CCL
2026